Equities researchers at Zacks Research boosted their Q2 2025 earnings per share (EPS) estimates for Universal Display in a ...

Stock analysts at Zacks Research increased their Q1 2025 earnings per share estimates for BioMarin Pharmaceutical in a ...

A recent ransomeware attack targeted Zacks, an American investment firm, and a cybercriminal claimed to have stolen records ...

ACM Research, Inc. (ACMR) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Zacks Investment Research recently disclosed that it suffered a data breach that compromised the sensitive personal data of millions of individuals ...

Wall Street expects a year-over-year decline in earnings on higher revenues when FactSet Research (FDS) reports results for the quarter ended February 2025. While this widely-known consensus outlook ...

The fund pursues its investment objectives by applying a hybrid research process, which uses both quantitative and qualitative criteria. The Advisor uses the Zacks Rank, a proprietary model ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Eli Lilly and Co. and ...

Below are three quality stocks to buy off the rising 200-day moving average: Zacks Rank #2 (Buy) stock On Holding is an emerging leader in the running shoe category. The company has delivered ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $15 million in its fourth quarter. The San Diego-based company said it had a loss of 18 cents per share.